Dr. Duma has the world’s first experience of injecting autologous mesenchymal fat-derived stem cells directly into the ventricles of the brain for treatment of neurodegenerative disorders like Alzheimer’s Disease, ALS, MS, and chronic traumatic encephalopathy.
He has experienced remarkable results and will share his research and news of his FDA approval for a Phase 1 trial.
Christopher Duma, MD, FACS
Medical Director, Hoag Brain Tumor Program,
Founder and President, Regeneration Biomedical, Inc.
CEO, NutriTheory, Inc.,
CEO and Founder, The Music-Heals Project,
Founder, Chairman of the Board
CMIO, DatCard Systems, Inc